The Zacks Analyst Blog Highlights iPath Lead Subindex TR Sm Index ETN, Simplify Tail Risk Strategy ETF, iPatha.B Cotton Subindex TR ETN, Tuttle Capital Short Innovation ETF and Extended Dur Treasury Index ETF Vanguard

EDV SARK

For Immediate Release

Chicago, IL – September 23, 2022 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. ETFs recently featured in the blog include: iPath Lead Subindex TR Sm Index ETN , Simplify Tail Risk Strategy ETF , iPatha.B Cotton Subindex TR ETN , Tuttle Capital Short Innovation ETF (SARK - Free Report) and Extended Dur Treasury Index ETF Vanguard (EDV - Free Report) .

Here are highlights from Thursday’s Analyst Blog:

ETFs That Won After Fed Rate Hike

The Federal Reserve hike benchmark interest rates by another 75 bps and indicated it will keep hiking well above the current level to tame sky-high inflation. Fed officials signaled the intention of continuing to hike until the funds level hits a “terminal rate,” or end point, of 4.6% in 2023, per a CNBC article. That implies a quarter-point rate hike next year but no decreases.

The median Federal Funds rates are now projected to be 4.4% for 2022 (from 3.4% projected in June). For 2023, the same is projected to be 4.6% (from 3.8% in June) and for 2024, the same is projected to be 3.9% (from 3.4% in 2024).

The Fed also hiked its inflation forecast for the year. The central bank now expects the median inflation rate to jump to 5.4% this year, higher than its previous forecast of 5.2%. PCE inflation expectation has gone up to 2.8% for 2023 from 2.6% projected in December. The Fed downgraded its forecast for 2022 median real GDP growth from 1.7% in June to 0.2% for 2022. It lowered the growth rate expectations for 2023 and 2024 to 1.2% and 1.7% from 1.7% and 1.9%, respectively.

With the possibility of a hawkish Fed in 2022 and 2023, short-term government bond yields rose. Two-year U.S. treasury yield jumped to4.02% on Sep 21 from 3.96% recorded on the day earlier. Benchmark bond yields fell to 3.51% from 3.57% recorded on Sep 20. Key U.S. equity indexes dropped post Fed meeting.

Against this backdrop, below we highlight a few ETFs that rose yesterday. These ETFs mainly came from the areas like commodities, alternative ETFs and inverse ETFs.

ETFs in Focus  

iPath Lead Subindex TR Sm Index ETN – Up 6.80%

The underlying Bloomberg Lead Subindex Total Return reflects the returns that are potentially available through an unleveraged investment in the futures contracts on lead. The fund charges 70 bps in fees.

Simplify Tail Risk Strategy ETF – Up 5.5%

This ETF is active and does not track a benchmark. The Simplify Tail Risk Strategy ETF seeks to provide investors with a standalone solution for hedging diversified portfolios against severe equity market selloffs. The fund charges 50 bps in fees and yields 7.80% annually.

iPatha.B Cotton Subindex TR ETN – Up 3.7%

The underlying Bloomberg Cotton Subindex Total Return reflects the returns that are potentially available through an unleveraged investment in the futures contracts on cotton. The fund charges 45 bps in fees.

Tuttle Capital Short Innovation ETF – Up 2.7%

This ETF is active and does not track a benchmark. The AXS Short Innovation Daily ETF seeks the daily inverse investment results and is intended to be used as a short-term trading vehicle. The fund charges 75 bps in fees.

Extended Dur Treasury Index ETF Vanguard – Up 2.4%

The underlying Bloomberg U.S. Treasury STRIPS 20—30 Year Equal Par Bond Index includes zero-coupon U.S. Treasury securities, which are backed by the full faith and credit of the U.S. government, with maturities ranging from 20 to 30 years. The fund charges 6 bps in fees and yields 3.01% annually.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.

Get it free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

https://www.zacks.com                                                  

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s an American AI company that’s riding low right now, but it has rounded up clients like BMW, GE, Dell Computer, and Bosch. It has prospects for not just doubling but quadrupling in the year to come. Of course, all our picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up